Related Experiment Video

Updated: May 4, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

17.8K

MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors

Marianne Berwick1, Jamie MacArthur, Irene Orlow

  • 1Departments of Internal Medicine and Dermatology, University of New Mexico, Albuquerque, NM, USA.

Pigment Cell & Melanoma Research
|January 11, 2014
PubMed

Insights

The rare MITF E318K gene variant is linked to melanoma risk. This risk is higher in individuals with dark hair or fewer moles, independent of MC1R variants.

Area of Science:

  • Genetics
  • Dermatology
  • Cancer Research

Background:

  • The microphthalmia-associated transcription factor (MITF) gene plays a crucial role in melanocyte development and is implicated in various pigmentation disorders.
  • A rare germline variant, E318K, in the MITF gene has been previously suggested to be associated with melanoma risk.

Purpose of the Study:

  • To confirm the independent association of the MITF E318K variant with melanoma.
  • To investigate potential interactions between MITF E318K and other risk factors, including hair color, nevus count, and MC1R variants.

Main Methods:

  • Case-control study design.
  • Statistical analysis including odds ratios (OR) and 95% confidence intervals (CI) to assess the association between MITF E318K and melanoma.
  • Stratified analyses were performed to evaluate effect modification by hair color, mole count, and MC1R variants.

Main Results:

  • The MITF E318K variant showed an independent association with melanoma (OR = 1.7, 95% CI = 1.1–2.7, P = 0.03).
  • The association was stronger in individuals with dark hair (P-interaction = 0.03) and those with no moles (P-interaction < 0.01).
  • No significant interaction was observed between MITF E318K and MC1R 'red hair variants'.

Conclusions:

  • The MITF E318K germline variant is a confirmed risk factor for melanoma.
  • Its impact on melanoma risk is modulated by pigmentation phenotypes, particularly hair color and mole count.
  • These findings highlight the complex genetic architecture of melanoma and the importance of considering gene-gene and gene-environment interactions.
Keywords:
Case-controlstudyMITFmelanomarisk factorssingle nucleotide polymorphism

More Related Videos

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model10:23

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

13.1K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

8.6K

Related Concept Videos

Pigmentation01:19

Pigmentation

The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
3.8K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81